Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEVIRAPINE Cause Dermatitis exfoliative generalised? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Dermatitis exfoliative generalised have been filed in association with NEVIRAPINE (Nevirapine). This represents 0.3% of all adverse event reports for NEVIRAPINE.

18
Reports of Dermatitis exfoliative generalised with NEVIRAPINE
0.3%
of all NEVIRAPINE reports
0
Deaths
10
Hospitalizations

How Dangerous Is Dermatitis exfoliative generalised From NEVIRAPINE?

Of the 18 reports, 10 (55.6%) required hospitalization, and 1 (5.6%) were considered life-threatening.

Is Dermatitis exfoliative generalised Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEVIRAPINE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does NEVIRAPINE Cause?

Foetal exposure during pregnancy (1,337) Drug resistance (862) Virologic failure (813) Viral mutation identified (518) Death (514) Exposure during pregnancy (462) Pathogen resistance (356) Treatment failure (340) Lipodystrophy acquired (288) Maternal exposure during pregnancy (283)

What Other Drugs Cause Dermatitis exfoliative generalised?

ALLOPURINOL (192) DUPILUMAB (162) METHOTREXATE (151) SULFAMETHOXAZOLE\TRIMETHOPRIM (140) AMOXICILLIN (122) ADALIMUMAB (113) PANTOPRAZOLE (105) SECUKINUMAB (96) VANCOMYCIN (92) AMLODIPINE (91)

Which NEVIRAPINE Alternatives Have Lower Dermatitis exfoliative generalised Risk?

NEVIRAPINE vs NEXAVAR NEVIRAPINE vs NEXIUM NEVIRAPINE vs NEXPLANON NEVIRAPINE vs NIACIN NEVIRAPINE vs NIACINAMIDE

Related Pages

NEVIRAPINE Full Profile All Dermatitis exfoliative generalised Reports All Drugs Causing Dermatitis exfoliative generalised NEVIRAPINE Demographics